For: | Takenaka T, Inoue T, Watanabe Y. How the kidney hyperfiltrates in diabetes: From molecules to hemodynamics. World J Diabetes 2015; 6(4): 576-582 [PMID: 25987955 DOI: 10.4239/wjd.v6.i4.576] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v6/i4/576.htm |
Number | Citing Articles |
1 |
Habib Yaribeygi, Thozhukat Sathyapalan, Mina Maleki, Tannaz Jamialahmadi, Amirhossein Sahebkar. Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review. Life Sciences 2020; 240: 117090 doi: 10.1016/j.lfs.2019.117090
|
2 |
Yang Yang, Gaosi Xu. Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.872918
|
3 |
Liwen Bao, Xiufang Gao, Kun Xie, Yong Li. Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.716083
|
4 |
Habib Yaribeygi, Alexandra E. Butler, Stephen L. Atkin, Niki Katsiki, Amirhossein Sahebkar. Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways. Journal of Cellular Physiology 2019; 234(1): 223 doi: 10.1002/jcp.26851
|
5 |
A. N. Kulikov, O. N. Beresneva, M. M. Parastaeva, S. V. Okovityi, G. T. Ivanova, D. Yu. Ivkin, A. S. Ivkina, E. N. Levykina, M. I. Zaraiskii, A. A. Karpov, A. G. Kucher, I. M. Zubina, O. V. Galkina, I. G. Kaiukov. INFLUENCE OF EMPAGLIFLOZIN ON THE KIDNEYS IN NORMOGLYCEMIC RATS WITH HEART FAILURE. Nephrology (Saint-Petersburg) 2017; 21(2): 83 doi: 10.24884/1561-6274-2017-21-2-83-92
|
6 |
Ping Hu, Xiang-Hai Zhou, Xin Wen, Linong Ji. Predictors of Renal Function Decline in Chinese Patients with Type 2 Diabetes Mellitus and in a Subgroup of Normoalbuminuria: A Retrospective Cohort Study. Diabetes Technology & Therapeutics 2016; 18(10): 635 doi: 10.1089/dia.2016.0115
|
7 |
Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung. Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis. Endocrinology and Metabolism 2023; 38(4): 359 doi: 10.3803/EnM.2023.1764
|